| Literature DB >> 32344812 |
Andrey S Marchev1, Milen I Georgiev1.
Abstract
Cosmeceuticals are hybrids between cosmetics and pharmaceuticals which are being designed for a dual purpose: (1) To provide desired esthetical effects and (2) simultaneously treat dermatological conditions. The increased demand for natural remedies and the trends to use natural and safe ingredients resulted in intensive cultivation of medicinal plants. However, in many cases the whole process of plant cultivation, complex extraction procedure, and purification of the targeted molecules are not economically feasible. Therefore, the desired production of natural cosmetic products in sustainable and controllable fashion in the last years led to the intensive utilization of plant cell culture technology. The present review aims to highlight examples of biosynthesis of active ingredients derived through plant in vitro systems with potential cosmeceutical application. The exploitation of different type of extracts used in a possible cosmeceutical formulation, as well as, their activity tested in in vitro/in vivo models is thoroughly discussed. Furthermore, opportunities to manipulate the biosynthetic pathway, hence engineering the biosynthesis of some secondary metabolites, such as anthocyanins, have been highlighted.Entities:
Keywords: anthocyanins; bioreactor cultivation; cosmeceuticals; gene expression; metabolic engineering; plant in vitro systems
Mesh:
Substances:
Year: 2020 PMID: 32344812 PMCID: PMC7248771 DOI: 10.3390/molecules25092006
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Small-scale production of secondary metabolites used as cosmeceuticals.
| Plant Species | Culture Type | Bioreactor Volume and Type | Operational Conditions | Metabolite Production, mg/L | Ref. |
|---|---|---|---|---|---|
| Anthocyanins | |||||
| Suspension | Stirred tank (2-L) | 25 °C; agitation: 75 rpm; flow rate: 0.075–0.15 vvm; 5000 lux continuous fluorescent light | 387 | [ | |
| Suspension | Stirred tank (20-L) | 25 °C; agitation: 100 rpm; flow rate: 0.2 vvm; 5000 lux continuous fluorescent light | 1200 | [ | |
| Suspension | Airlift (0.5-L) | 25 °C in dark; flow rate: 80 mL/min | 33 | [ | |
|
| Suspension | Stirred tank (2-L) | 25 °C; agitation: 150 rpm; flow rate: 0.1 vvm; 27 W/m2 light irradiation | 1650 | [ |
| Resveratrol | |||||
| Suspension | Stirred tank (2-L) | 23 °C in dark; agitation: 50 rpm; flow rate: 0.025 vvm | 209 | [ | |
| Suspension | Stirred tank (14-L) | 23 °C in dark; agitation: 50 rpm; flow rate: 0.025 vvm | 72 | [ | |
| Suspension | Stirred tank (5-L) | 23 °C in dark; agitation: 100 rpm; flow rate: 20.0–780.0 L/min | 66 | [ | |
| Rosmarinic acid | |||||
| Hairy roots | Nutrient sprinkle (5-L) | 26 °C in dark; 40 s pump operation/50 s breaks | 477.13 | [ | |
| Shoots | Nutrient sprinkle (10-L) | 26 °C; 16 h/8 h light/dark; 25 s pump operation/2.5 s breaks | 38.26 | [ | |
| Chlorogenic acid | |||||
| Shoots | Nutrient sprinkle (10-L) | 26 °C; 16 h/8 h light/dark; 25 s pump operation/2.5 s breaks | 0.07 | [ | |
| Hairy roots | Nutrient sprinkle (5-L) | 26 °C; 40 s pump operation/1.5 min breaks | 448 | [ | |
| Adventitious roots | Air lift (3-L) | 22 °C in dark; flow rate: 0.1 vvm | 78.22 | [ | |
| Adventitious roots | Bulb type (3-L) | 22 °C in dark; 0.1 vvm flow rate | 24.68 | [ | |
| Caffeic acid | |||||
| Shoots | Nutrient sprinkle (10-L) | 26 °C; 16 h/8 h light/dark; 25 s pump operation/2.5 s breaks | 0.07 | [ | |
| Hairy roots | Nutrient sprinkle (5-L) | 26 °C; 40 s pump operation/1.5 min breaks | 302 | [ | |
| Verbascoside | |||||
|
| Suspension | Stirred tank (3-L) | 26 °C in dark; agitation: 100 rpm; flow rate: 1/L min | 445.44 | [ |
|
| Suspension | Column bioreactor with pulsed aeration (1-L) | 26 °C in dark; 1/L min flow rate every 2 s | 496.30 | [ |
|
| Shoots | Nutrient sprinkle (5-L) | 26 °C; 40 s pump operation/2 min breaks | 11.4 | [ |
Figure 1Illustration, presenting the biosynthetic pathway of colored anthocyanins. PAL, phenylalanine ammonia lyase (EC 4.3.1.24); TAL, tyrosine ammonia lyase (EC 4.3.1.23); C4H, cinnamate 4-hydroxylase (EC 1.14.14.91); ACC, acetyl-CoA carboxylase (EC 6.4.1.2); 4CL, 4-coumarate-CoA ligase (EC 6.2.1.12); CHS, chalcone synthase (EC 2.3.1.74); STS, stilbene synthase (EC 2.3.1.95); CHI, chalcone isomerase (EC 5.5.1.6); F3′H, flavonoid 3’-hydroxylase (EC 1.14.13.21); F3′5′H, flavonoid 3´5´-hydroxylase (EC 1.14.13.88); FNS, flavones synthase (EC 1.14.11.22); F3H, flavanone 3-hydroxylase (EC 1.14.11.9); DFR, dihydroflavonol 4-reductase (EC 1.1.1.219); ANS, anthocyanidin synthase (EC 1.14.20.4); LAR, leucoanthocyanidin reductase (EC 1.17.1.3); ANR, anthocyanidin reductase (EC 1.3.1.112); UFGT, UDP-glucose:flavonoid-3-O-glycosyltransferase (EC 2.4.1.115); GST, glutathione S-transferase (EC EC 2.5.1.18); MATE, multidrug and toxic compound extrusion transporter; ABC, ATP-binding cassette transporter. Phenylalanine is deaminated by PAL to form trans-cinnamic acid that is further converted into para-coumaric acid by C4H. Para-coumaric acid is conjugated with coenzyme A by the enzyme 4CL to obtain para-coumaroyl-CoA. The latter is condensed with three molecules of malonyl-CoA by CHS to generated naringenin chalcone. Subsequently, CHI stereospecifically converts the chalcone to its isomer naringenin. The B ring of naringenin is hydroxylated by F3´H or F3´5´H to produce eriodyctiol or penthahydroxy-flavanone. The (2S)-flavanones are next subjected to modification by the conversion of F3H into dihydroflavonols (dihydroquercetin, dihydrokaempferol and dihydromyricetin). Dihydrokaempferol could be directly oxidized by F3´H and F3´5´H to dihydroquercetin and dihydromyricetin. The obtained dihydroflavonols are reduced to colorless leucoanthocyanidins by DFR, which are then oxidized to colored anthocyanidins by the activity of ANS (synonyms leucocyanidin oxygenase: LDOX). Further, glycosylation is performed by UFGT, which occurs in the cytoplasm and produces chemically stable water-soluble pigments.
Activities of plant cell culture extracts and their modulation activity on gene expression in skin cells in vitro models.
| Plant Species and Extract Type | Concentration of the Extract, μg/mL | Gene/Protein Expression | Main Activity | Ref. |
|---|---|---|---|---|
| 8000 | IL-1β, IL-1α, TNFα PGE2 inhibition | Anti-inflammatory activity | [ | |
| 500 | Tyrosinase inhibition | Melanin inhibition | [ | |
| 20 | COL I and pro-collagen I induction | Collagen synthesis and protection | [ | |
| 50 | MMP1, hyaluronidase, elastase inhibition | Collagen synthesis and protection | [ | |
| 100 | COL I and COL III induction, MMP1, MMP3 and MPP9 inhibition | Collagen synthesis and protection | [ | |
| 100 | Cyclin B1, cyclin E1 induction | Retard the signs of senescence | [ | |
| 3.6 | COL I and COL III induction, pro-collagen I and III induction, MMP1, MMP3 and MPP9 inhibition | Collagen synthesis and protection | [ | |
| 1000 | Tyrosinase inhibition | Melanin inhibition | [ | |
| 1000 | GBA, Smpd1 induction | Skin lipid production | [ |